Normoftal
Also known as: Eye Peptide Bioregulator, Retina Peptide, AKS-G Peptide
Key Facts: Normoftal
- Category
- Cognitive
- FDA Status
- Not FDA Approved
- Clinical Status
- Approved in Russia - Clinical use for retinal support
- Administration
- Oral capsules, before meals
- Typical Dose
- 2 capsules 1-2x daily
- Frequency
- 1-2x daily, before meals
- Duration
- 30-day courses, repeat after 2-6 months
Mechanism of Action
Normoftal normalizes eye function by reducing peptide deficiency and restoring protein synthesis inside retinal cells. Contains peptide AKS-G (lysine, glutamic acid). May have neuroprotective effects on retinal neurons by modulating gene expression and protein synthesis, helping preserve the integrity and function of retinal nerve cells critical for transmitting visual information to the brain.
Research Summary
From 1995 to 2010, at the St. Petersburg Institute of Bioregulation and Gerontology, 1500 patients with retinal pathology were treated: 40.3% with macular degeneration, 30.3% with diabetic retinopathy, 23.0% with retinitis pigmentosa. Improved visual functions were reported in 95% of patients. Research suggests it may aid treatment of glaucoma, diabetic retinopathy, and age-related macular degeneration.
Dosing Information
Typical Dosingⓘ
Community experience
2 capsules 1-2x daily
2-4 capsules per day
1-2x daily, before meals
Khavinson retinal bioregulator with extensive clinical use in Russia. Studies report 95% of patients with macular degeneration, diabetic retinopathy, or retinitis pigmentosa showed improved visual function. Often combined with Visoluten (natural retina peptide extract). May increase effectiveness of standard treatments for glaucoma and cataracts.
Research Dosingⓘ
Scientific studies
Khavinson bioregulator dosing - clinically used in Russia
Doses from Studies
20-40 mg daily (therapy)
Russian Clinical Studies 1995-2010 - 1500 patients with retinal pathology - 95% improvement ↗
20 mg daily (prevention)
Khavinson Protocol - Prevention of age-related eye conditions ↗
Duration
30-day courses, repeat after 2-6 months
Administration
Oral capsules, before meals
Timing & Administration
Best Time to Take
Morning and evening, before meals
1-2 times daily depending on protocol
Food Recommendation
With or without food
Why This Timing?
Split dosing for therapeutic use. Prevention protocols use once daily dosing.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Well-tolerated with no reported side effects
- ●No allergic reactions in clinical studies
- ●Individual intolerance to components (rare)
- ●Should not replace standard eye treatments
References
Research This Peptide Further
Frequently Asked Questions
What does Normoftal do?
A synthesized Khavinson peptide bioregulator containing short peptides (2-4 amino acids) derived from retinal tissue. Developed to normalize retinal function and support eye health. Clinical studies in Russia report improved visual function in 95% of patients with various retinal pathologies.
How does Normoftal work?
Normoftal normalizes eye function by reducing peptide deficiency and restoring protein synthesis inside retinal cells. Contains peptide AKS-G (lysine, glutamic acid). May have neuroprotective effects on retinal neurons by modulating gene expression and protein synthesis, helping preserve the integrity and function of retinal nerve cells critical for transmitting visual information to the brain.
Is Normoftal FDA approved?
No, Normoftal is not currently FDA approved. Current status: Approved in Russia - Clinical use for retinal support
What are the side effects of Normoftal?
Reported side effects include: Well-tolerated with no reported side effects, No allergic reactions in clinical studies, Individual intolerance to components (rare), Should not replace standard eye treatments. Individual responses vary based on dosage, duration, and personal health factors.
What is the typical dose of Normoftal?
Community-reported common dose: 2 capsules 1-2x daily (1-2x daily, before meals). Range: 2-4 capsules per day. Administration: Oral capsules, before meals. Community-reported doses. Not FDA approved. Not a substitute for standard eye care. Consult ophthalmologist.
Related Peptides
Peptides commonly compared with Normoftal or used in similar applications.
Selank
Clinical TrialsA synthetic peptide derived from tuftsin, an immunomodulatory peptide. Approved in Russia for anxiety and nootropic effects. Known for anxiolytic properties without sedation.
CognitiveSemax
Clinical TrialsA synthetic peptide derived from ACTH (4-10) fragment with added Pro-Gly-Pro sequence. Approved in Russia for stroke and cognitive enhancement. Known for nootropic and neuroprotective effects.
CognitiveCerebrolysin
Clinical TrialsA mixture of low-molecular-weight neuropeptides derived from pig brain. Approved in many countries for stroke, traumatic brain injury, and dementia.
CognitiveDihexa
PreclinicalA potent cognitive-enhancing peptide derived from angiotensin IV. Reported to be 10 million times more potent than BDNF at promoting synaptogenesis.
CognitiveGB-115
Clinical TrialsA dipeptide anxiolytic and nootropic that acts as a CCK-1 (cholecystokinin) receptor antagonist. Developed in Russia with completed Phase 3 trials for anxiety. Users report significant improvements in focus, attention, and ADHD-like symptoms.
CognitivePE-22-28
PreclinicalA synthetic heptapeptide (7 amino acids) derived from Spadin, a naturally occurring antidepressant peptide. PE-22-28 is a shorter, more stable analog that retains the antidepressant and anxiolytic properties of Spadin. Works by blocking TREK-1 potassium channels in the brain.
CognitiveWant updates on Normoftal research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.